Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Vaccinations01:51

Vaccinations

45.1K
Overview
45.1K
Pulmonary Tuberculosis I01:29

Pulmonary Tuberculosis I

297
Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
297
Pulmonary Tuberculosis II01:28

Pulmonary Tuberculosis II

296
Tuberculosis, or TB, is a bacterial infectious disease caused by Mycobacterium tuberculosis. While its primary impact is on the lungs, leading to pulmonary tuberculosis, it can also affect various other organs, a condition referred to as extrapulmonary tuberculosis.
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
296
Pulmonary Tuberculosis V01:28

Pulmonary Tuberculosis V

225
Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
225
Transmission-based Precautions II: Airborne and Protective Environment01:25

Transmission-based Precautions II: Airborne and Protective Environment

1.3K
Transmission-based precautions are for patients infected or suspected to be infected (or colonized) with organisms posing a significant risk to others. The transmission precautions include airborne and protective environment precautions.
Airborne precautions:
Use airborne precautions when treating patients known or suspected to have diseases that spread through the air—for example, tuberculosis or measles. These organisms are present in smaller droplets expelled by an infected person and...
1.3K
Pneumonia I: Introduction01:30

Pneumonia I: Introduction

300
Pneumonia is an acute respiratory infection that targets the lungs, specifically the alveoli. These tiny air sacs, essential for oxygen exchange, become engorged with pus and fluid, severely hindering breathing, decreasing oxygen absorption, and causing significant pain and discomfort during respiration.
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
300

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same authorSame journal

Lyme disease in Poland in 2023.

Przeglad epidemiologiczny·2026
Same authorSame journal

Pertussis in Poland in 2023.

Przeglad epidemiologiczny·2026
Same author

Public spending on immunisation in Poland.

Frontiers in public health·2025
Same author

Chickenpox in Poland in 2023.

Przeglad epidemiologiczny·2025
Same author

Mumps in Poland in 2023.

Przeglad epidemiologiczny·2025
Same author

Measles in Poland: 2022-2023.

Przeglad epidemiologiczny·2025

Related Experiment Video

Updated: Aug 17, 2025

Evaluation of Host-Pathogen Responses and Vaccine Efficacy in Mice
08:52

Evaluation of Host-Pathogen Responses and Vaccine Efficacy in Mice

Published on: February 22, 2019

10.8K

Pertussis in Poland in 2020.

Agnieszka Rumik1, Iwona Paradowska-Stankiewicz1

  • 1National Institute of Public Health NIH - National Research Institute, Department of Epidemiology of Infectious Diseases and Surveillance.

Przeglad Epidemiologiczny
|December 16, 2022
PubMed
Summary

Pertussis cases in Poland significantly decreased in 2020 due to SARS-CoV-2 restrictions, but remain a public health concern. Maintaining high vaccination rates is crucial to prevent future epidemics of this infectious disease.

Keywords:
2020Polandepidemiologyinfectious diseasespertussis

More Related Videos

Symptom Assessment of Patients with Allergic Rhinitis Using an Allergen Exposure Chamber
08:47

Symptom Assessment of Patients with Allergic Rhinitis Using an Allergen Exposure Chamber

Published on: March 3, 2023

2.5K
Author Spotlight: Advancements in Multiplex Detection of Respiratory Viruses
03:53

Author Spotlight: Advancements in Multiplex Detection of Respiratory Viruses

Published on: November 10, 2023

1.3K

Related Experiment Videos

Last Updated: Aug 17, 2025

Evaluation of Host-Pathogen Responses and Vaccine Efficacy in Mice
08:52

Evaluation of Host-Pathogen Responses and Vaccine Efficacy in Mice

Published on: February 22, 2019

10.8K
Symptom Assessment of Patients with Allergic Rhinitis Using an Allergen Exposure Chamber
08:47

Symptom Assessment of Patients with Allergic Rhinitis Using an Allergen Exposure Chamber

Published on: March 3, 2023

2.5K
Author Spotlight: Advancements in Multiplex Detection of Respiratory Viruses
03:53

Author Spotlight: Advancements in Multiplex Detection of Respiratory Viruses

Published on: November 10, 2023

1.3K

Area of Science:

  • Epidemiology
  • Infectious Diseases
  • Public Health

Background:

  • Pertussis (whooping cough) cases in Poland dropped by over 50% in 2020 compared to 2019, largely due to COVID-19 related contact restrictions.
  • Pertussis poses the greatest risk to young children but can affect all ages, with adults serving as a significant reservoir for Bordetella pertussis.

Purpose of the Study:

  • To evaluate the epidemiological situation of pertussis in Poland during 2020.
  • To compare pertussis incidence in 2020 with previous years.
  • To assess the vaccination status of children against pertussis.

Main Methods:

  • Analysis of unit reports of pertussis cases registered in the EpiBaza system.
  • Utilizing data from annual bulletins on infectious diseases and vaccinations in Poland for 2020.

Main Results:

  • 753 pertussis cases were recorded in 2020, with an incidence rate of 1.96 per 100,000 population.
  • The highest incidence was observed in children aged 0-4 years, with significant rates also in older children and adolescents.
  • Approximately 27% of pertussis cases required hospitalization, and one fatality was reported.

Conclusions:

  • Despite a significant decrease in pertussis cases in 2020, the disease remains a public health issue due to waning immunity.
  • Maintaining high population vaccination coverage (over 92-94%) is essential to prevent future pertussis outbreaks.
  • Booster vaccinations for adults are recommended every 10 years to sustain immunity.